Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Promising cancer treatments were found, but the manufacturer closed.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Provenge extends prostate cancer survival by about 4 months.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.